Full-Time

Sr. Manager

Posted on 12/23/2024

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology

Compensation Overview

$140k - $185kAnnually

Senior, Expert

San Francisco, CA, USA

Hybrid schedule with 2-3 designated days in Bay Area office locations (Palo Alto and San Francisco).

Category
Human Resources
People & HR

You match the following BridgeBio's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Minimum of 7+ years of experience solely focused Health & Welfare management, experience in biotech a plus
  • Working knowledge of current federal, state, and local employment laws and regulations including, but not limited to, DOL, IRS, HIPAA, ERISA, COBRA, and FMLA
  • Benefit Broker engagement and vendor management, including negotiations, performance monitoring, RFPs, and contract termination
  • Have led a minimum of 3 annual benefits renewal cycles
  • Proven experience managing self-funded plans, budget control, and account reconciliation
  • Direct people management experience
  • Demonstrated stakeholder management in complex and matrixed organizations
  • Possess full understanding of the impactful and benefit of wellness programs
  • Exposure to Workday Benefits Administration functionality, an advantage
  • Ability to work a hybrid schedule with 2-3 designated days in Bay Area office locations (Palo Alto and San Francisco)
  • Bachelor’s Degree in Human Resources, Business Administration, related field, or translated work experience
  • CBP or related certification a plus
Responsibilities
  • Provide direct oversight of all US-based Benefits Programs with seamless day-to-day administration, platform management, policy design, and related processes to deliver an excellent employee experience
  • Evolve the US Benefits strategy, including benchmarking and research of emerging offerings and programs
  • Optimize and evolve benefits resources and calendared education opportunities
  • Determinate ‘if, when, and how’ to transition to a self-funded model
  • Provide direction, development, and support to a People Operations Associate
  • Act as the primary contact to navigate complex benefits issues, monitor high-cost claims, identify trends, and manage accurate budget tracking
  • Lead the annual US benefits renewal process and manage the full cycle for open enrollment, including OE sessions and written communication campaigns
  • Develop collaborative partnerships and provide oversight of our Benefits Broker, Leave Administrator, and other providers
  • Work efficiently and collaboratively with People Partners, Payroll, Accounting, and senior management
  • Manage the compliance calendar and adherence, including testing, audits, and reporting (i.e., SOX, 5500, Employee Handbook, EEO-1, etc.)
  • Ensure programs and resources (e.g. COVID, WVPP, and Worker’s Compensation) are tightly and timely managed
  • Serve as a non-voting member of the 401(k) committee
  • Participation in additional projects and manage other responsibilities as appropriate
Desired Qualifications
  • Exposure to Workday Benefits Administration functionality, an advantage
  • CBP or related certification a plus

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company uses a decentralized subsidiary model, allowing each subsidiary to concentrate on specific therapies while sharing central resources. This structure enhances efficiency and enables the advancement of multiple drug programs at once. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Their goal is to create significant therapeutic improvements by targeting diseases at their genetic source. With over 15 drug programs aimed at 20 different genetic diseases, BridgeBio aims to bring treatments to market more quickly than traditional biopharma processes. The company promotes a culture of independent thinking and transparency, which supports rapid, data-driven decision-making.

Company Stage

IPO

Total Funding

$704.4M

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

4%

1 year growth

1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investment by Norges Bank shows strong investor confidence in BridgeBio.
  • Partnership with PANTHERx Rare enhances market penetration for rare disease therapies.
  • KRAS inhibitors development positions BridgeBio in a promising cancer treatment market.

What critics are saying

  • Alnylam's RNAi therapy poses competitive pressure on BridgeBio's Attruby.
  • Decentralized model may challenge cohesive strategic direction across programs.
  • Increased competition in KRAS inhibitors could impact BridgeBio's market share.

What makes BridgeBio unique

  • BridgeBio employs a decentralized subsidiary model for efficient drug development.
  • Focus on genetic diseases allows targeting conditions with well-understood genetic causes.
  • Partnerships with specialty pharmacies enhance patient access to rare disease therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Performance Bonus

Company Equity

Unlimited Paid Time Off

INACTIVE